TORONTO, April 18, 2023 Today, Arch Biopartners Inc., , a clinical stage company focused on the development of novel therapeutics targeting organ inflammation, announced that it has safely. | April 18, 2023
07.02.2023 - TORONTO, Feb. 07, 2023 (GLOBE NEWSWIRE) - Today, Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), a clinical stage company focused on the development of innovative technologies and novel therapeutics targeting .
09.02.2022 - TORONTO, Feb. 08, 2022 (GLOBE NEWSWIRE) - Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the Company has arranged a shares for debt transaction to settle an aggregate of $424,767.07 in . Seite 1
A&W Revenue Royalties Income Fund (T.AW.UN) hit a new 52-week high of $39.66 on Wednesday. A&W reported Same Store Sales Growth was 16.8% for Q3 2021 as compared to Q3 2020.. Same Store Sales Growth (1) for the year to date period ended September 12, .
A&W Revenue Royalties Income Fund (T.AW.UN) hit a new 52-week high of $39.66 on Wednesday. A&W reported Same Store Sales Growth was 16.8% for Q3 2021 as compared to Q3 2020.. Same Store Sales Growth (1) for the year to date period ended September 12, .